HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions

Abstract

Numerous microarray-based gene expression studies performed on several types of solid tumors revealed significant changes in key genes involved in progression and regulation of the cell cycle, including AURKA that is known to be overexpressed in many types of human malignancies. Tumor hypoxia is associated with poor prognosis in several cancer types, including breast cancer (BC). Since hypoxia is a condition that influences the expression of many genes involved in tumorigenesis, proliferation, and cell cycle regulation, we performed a microarray-based gene expression analysis in order to identify differentially expressed genes in BC cell lines exposed to hypoxia. This analysis showed that hypoxia induces a down-regulation of AURKA expression. Although hypoxia is a tumor feature, the molecular mechanisms that regulate AURKA expression in response to hypoxia in BC are still unknown. For the first time, we demonstrated that HIF-1 activation downstream of hypoxia could drive AURKA down-regulation in BC cells. In fact, we found that siRNA-mediated knockdown of HIF-1a significantly reduces the AURKA down-regulation in BC cells under hypoxia. The aim of our study was to obtain new insights into AURKA transcriptional regulation in hypoxic conditions. Luciferase reporter assays showed a reduction of AURKA promoter activity in hypoxia. Unlike the previous findings, we hypothesize a new possible mechanism where HIF-1, rather than inducing transcriptional activation, could promote the AURKA down-regulation via its binding to hypoxia-responsive elements into the proximal region of the AURKA promoter. The present study shows that hypoxia directly links HIF-1 with AURKA expression, suggesting a possible pathophysiological role of this new pathway in BC and confirming HIF-1 as an important player linking an environmental signal to the AURKA promoter. Since AURKA down-regulation overrides the estrogen-mediated growth and chemoresistance in BC cells, these findings could be important for the development of new possible therapies against BC.

Regulation of fatty acid binding proteins by hypoxia inducible factors 1α and 2α in the placenta: Relevance to pre-eclampsia

“…2B and C). Reduced luciferase activity of HRE in response to hypoxic exposure has been observed previously, although the mechanism behind this observation is not yet known [13]. CoCl 2 induced hypoxia on the other hand caused an increase in luciferase activity ( Fig.…”

Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus

“…In addition, Agnese et al . [9] reported that BE and CLO samples were positive for the Aurora kinase A transcript compared to controls, consistently with its overexpression reported in many types of human malignancies [10, 11], but there were no statistically significant quantitative differences in Aurora-A messenger RNA expression between CLO and BE and p53-positive immunostaining.…”

β-Catenin Links von Hippel-Lindau to Aurora Kinase A and Loss of Primary Cilia in Renal Cell Carcinoma

“…This could arise from reduced binding of HIF to the AURKA HIF responsive element as recently observed in breast cancer cell lines. 42 Alternately, it may suggest the existence of an alternate pathway as previously reported for colorectal carcinoma, in which HIF-1a bound to b-catenin precluding its association with T cell factor to prevent activation of its downstream targets. 30 High HIF-1a levels are associated with unfavorable prognosis in most cancers; however, patients with high HIF-1a expression have a better prognosis in ccRCC.…”